NCT01743339

Brief Summary

The primary purpose of this study is to test whether and how cognitive-behavioral therapy for insomnia (CBTi), a well-supported and highly effective insomnia treatment, may directly improve Posttraumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD) symptoms. The study is designed as a randomized controlled trial (RCT) to test the effect of CBTi on symptoms of PTSD and co-morbid depression prior to an evidence-based PTSD intervention and to assess the role of neurobiological processes and sleep architecture in mediating treatment outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 6, 2012

Completed
26 days until next milestone

Study Start

First participant enrolled

January 1, 2013

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

April 27, 2017

Status Verified

August 1, 2016

Enrollment Period

4.1 years

First QC Date

December 4, 2012

Last Update Submit

April 25, 2017

Conditions

Keywords

Randomized Controlled TrialCognitive TherapyStress Disorders, Post-TraumaticDepressionSleep

Outcome Measures

Primary Outcomes (1)

  • PTSD (intensity and frequency for each symptom, and remission)

    The Clinician Administered PTSD Scale (CAPS)will be used as our primary PTSD outcome measure.

    20 weeks

Secondary Outcomes (2)

  • Insomnia severity

    20 weeks

  • Depression

    20 weeks

Other Outcomes (3)

  • Sleep

    7 weeks.

  • Salivary Cortisol

    7 weeks

  • Inflammatory cytokine levels (IL-6)

    7 weeks

Study Arms (2)

Control

ACTIVE COMPARATOR

Control (brief check-in calls) and Cognitive Processing Therapy (12 individual weekly sessions)

Behavioral: Control

Cognitive Behavioral Therapy

EXPERIMENTAL

Cognitive Behavioral Therapy for Insomnia (4 individual therapy sessions over 5 weeks) and Cognitive Processing Therapy (12 individual weekly sessions)

Behavioral: Cognitive Behavioral Therapy

Interventions

Cognitive Behavioral Therapy for Insomnia(4 individual therapy sessions over 5 weeks) will consist of a standard, structured, multi-component CBT intervention (sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention) Cognitive Processing Therapy will consist of a standard, structured 12-session protocol (PTSD education, exploring personal impact of trauma, experiencing emotions related to thoughts of trauma, cognitive therapy, and applying healthy thoughts and behaviors) delivered in individual weekly sessions

Also known as: Cognitive-Behavioral Therapy for Insomnia, Cognitive Processing Therapy
Cognitive Behavioral Therapy
ControlBEHAVIORAL

Cognitive Processing Therapy will consist of a standard, structured 12-session protocol (PTSD education, exploring personal impact of trauma, experiencing emotions related to thoughts of trauma, cognitive therapy, and applying healthy thoughts and behaviors) delivered in individual weekly sessions.

Also known as: Cognitive Processing Therapy
Control

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • must be English-speaking
  • age 18-64 years old
  • with exposure to trauma from interpersonal violence in the past year
  • meet diagnostic criteria for full or subthreshold PTSD
  • meet diagnostic criteria for MDD
  • meet criteria for Insomnia Disorder

You may not qualify if:

  • untreated sleep disorders other than insomnia or nightmares
  • dementia or cognitive impairment
  • history of schizophrenia or bipolar I disorder
  • current suicidality
  • health conditions with immunological components or taking immunosuppressive therapies
  • active alcohol dependence
  • medication use including antipsychotics, opiate analgesics, and sleep medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rochester

Rochester, New York, 14642, United States

Location

Related Publications (1)

  • Pigeon WR, Heffner KL, Crean H, Gallegos AM, Walsh P, Seehuus M, Cerulli C. Responding to the need for sleep among survivors of interpersonal violence: A randomized controlled trial of a cognitive-behavioral insomnia intervention followed by PTSD treatment. Contemp Clin Trials. 2015 Nov;45(Pt B):252-260. doi: 10.1016/j.cct.2015.08.019. Epub 2015 Sep 4.

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticDepression

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Wilfred R. Pigeon, Ph.D.

    University of Rochester

    PRINCIPAL INVESTIGATOR
  • Kathi L. Heffner, Ph.D.

    University of Rochester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Psychiatry

Study Record Dates

First Submitted

December 4, 2012

First Posted

December 6, 2012

Study Start

January 1, 2013

Primary Completion

February 1, 2017

Study Completion

February 1, 2017

Last Updated

April 27, 2017

Record last verified: 2016-08

Locations